Profiel
Dr. Michael Schirner, MD, is a Managing Director at mivenion GmbH.
Dr. Schirner was previously employed as a Principal by Schering AG.
He received his undergraduate degree from the Friedrich Schiller University of Jena and a doctorate degree from Martin-Luther-Universität Halle-Wittenberg.
Eerdere bekende functies van Michael Schirner
Bedrijven | Functie | Einde |
---|---|---|
Bayer Schering Pharma AG | Corporate Officer/Principal | 01-01-2007 |
mivenion GmbH
mivenion GmbH Medical SpecialtiesHealth Technology mivenion GmbH offers personalized medical solutions for patients with inflammatory and autoimmune diseases. Its flagship product, Xiralite, enables the Rheumascan procedure that provides integrated solution for patients with inflammatory diseases in the hands. The company was founded by Michael Schirner and Malte Bahner in 2007 and is headquartered in Berlin, Germany. | Algemeen Directeur | - |
Opleiding van Michael Schirner
Friedrich Schiller University of Jena | Undergraduate Degree |
Martin-Luther-Universität Halle-Wittenberg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
mivenion GmbH
mivenion GmbH Medical SpecialtiesHealth Technology mivenion GmbH offers personalized medical solutions for patients with inflammatory and autoimmune diseases. Its flagship product, Xiralite, enables the Rheumascan procedure that provides integrated solution for patients with inflammatory diseases in the hands. The company was founded by Michael Schirner and Malte Bahner in 2007 and is headquartered in Berlin, Germany. | Health Technology |
Bayer Schering Pharma AG | Health Technology |